WuXi AppTec Co., Ltd. Class H (HK:2359) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
WuXi AppTec Co., Ltd. has announced a strategic move to sell its WuXi Advanced Therapies Inc. and Oxford Genetics Limited to Altaris LLC, a U.S.-based healthcare investment fund. This transaction is designed to maintain the delivery of crucial cell therapy services while aligning with WuXi’s commitment to client and patient priorities. Despite the sale, the company’s financial performance remains unaffected, and it continues to pursue its overarching mission to innovate in drug manufacturing and treatment solutions.
For further insights into HK:2359 stock, check out TipRanks’ Stock Analysis page.